| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |